Table 5.
Early morning saliva cortisol levels at baseline (day 0) and after 21 days of intervention (day 21) per treatment and in ITT, PP and modPP populations.
| Period 1 + 2 | p-Value 1 | ||
|---|---|---|---|
| DP | Placebo | ||
| ITT | |||
| Cortisol d0, 0 min | 3.36 ± 1.54; 3.20 (2.20) | 3.38 ± 1.44; 3.05 (2.18) | 0.973 |
| Cortisol d21, 0 min | 3.19 ± 1.45; 3.00 (2.20) | 3.78 ± 1.78; 3.50 (1.85) | 0.045 |
| Within group; p | 0.316 | 0.161 | |
| PP | |||
| Cortisol d0, 0 min | 3.38 ± 1.56; 3.20 (2.10) | 3.34 ± 1.44; 3.00 (2.05) | 0.784 |
| Cortisol d21, 0 min | 3.21 ± 1.45; 3.20 (2.20) | 3.83 ± 1.82; 3.50 (1.95) | 0.059 |
| Within group; p | 0.414 | 0.098 | |
| modPP | |||
| Cortisol d0, 0 min | 3.38 ± 1.64; 3.10 (1.90) | 3.38 ± 1.46; 3.10 (2.15) | 0.788 |
| Cortisol d21, 0 min | 3.03 ± 1.36; 2.90 (2.10) | 3.90 ± 1.91; 3.60 (2.05) | 0.033 |
| Within group; p | 0.248 | 0.170 | |
Data are presented as mean ± SD; median (IQR). 1 Mann-Whitney U-test. DP: dairy-based test product; Placebo: skimmed milk powder; d0: baseline; d21: 21 days of intervention.